The Gabra2–1 mutation demonstrates a striking parallel with the effects of ARHGEF9 mutation in human syndromes, whose symptoms include epilepsy, anxiety, mental retardation, aggressive behavior, sleep–wake cycle disruptions, early mortality, and hyperekplexia24–27. This evidence concerns the gene GABRA2 and epilepsy.